StockDrifts LogoStockDrifts

Pfizer Inc 13F Portfolio

Portfolio Manager
Pfizer INC
Performance
-7.89% (2026 Q2)
AUM (13F)
$170.37M
# of Holdings
17
Performance Rank
N/A
Allocation (Top 20)
100.02%
Latest filing
Q2 2026

Pfizer INC Holdings Map

Top 17 Pfizer INC Holdings

Top 10 holdings

StockCompany% Port.SharesValueActivityOwnershipAvg. CostDate
ALLO
ALLOGENE THERAPEUTICS INC
27.55%22.03M$46.9M
+0.00%(+0)
2025-Q2: 22.03M shares2025-Q3: 22.03M shares2025-Q4: 22.03M shares2026-Q1: 22.03M shares2026-Q2: 22.03M shares
$2.47(-19.68%)
2026-06-30
CELC
CELCUITY INC
17.35%295.7K$29.6M
+0.00%(+0)
2025-Q2: 349.4K shares2025-Q3: 349.4K shares2025-Q4: 349.4K shares2026-Q1: 295.7K shares2026-Q2: 295.7K shares
$14.00(+518.57%)
2026-06-30
ARVN
ARVINAS INC
16.24%3.46M$27.7M
+0.00%(+0)
2025-Q2: 3.46M shares2025-Q3: 3.46M shares2025-Q4: 3.46M shares2026-Q1: 3.46M shares2026-Q2: 3.46M shares
$21.90(-58.86%)
2026-06-30
PYXS
PYXIS ONCOLOGY INC
11.43%7.03M$19.5M
+0.00%(+0)
2025-Q2: 7.03M shares2025-Q3: 7.03M shares2025-Q4: 7.03M shares2026-Q1: 7.03M shares2026-Q2: 7.03M shares
$2.62(+15.11%)
2026-06-30
WVE
WAVE LIFE SCIENCES LTD
6.42%1.88M$10.9M
+0.00%(+0)
2025-Q2: 1.88M shares2025-Q3: 1.88M shares2025-Q4: 1.88M shares2026-Q1: 1.88M shares2026-Q2: 1.88M shares
$10.28(-49.44%)
2026-06-30
BHVN
BIOHAVEN LTD
4.7%505.6K$8.0M
+0.00%(+0)
2025-Q2: 505.6K shares2025-Q3: 505.6K shares2025-Q4: 505.6K shares2026-Q1: 505.6K shares2026-Q2: 505.6K shares
$43.66(-67.18%)
2026-06-30
CRBU
CARIBOU BIOSCIENCES INC
4.63%4.69M$7.9M
+0.00%(+0)
2025-Q2: 4.69M shares2025-Q3: 4.69M shares2025-Q4: 4.69M shares2026-Q1: 4.69M shares2026-Q2: 4.69M shares
$1.78(-9.30%)
2026-06-30
SPRO
SPERO THERAPEUTICS INC
3.13%2.36M$5.3M
+0.00%(+0)
2025-Q2: 2.36M shares2025-Q3: 2.36M shares2025-Q4: 2.36M shares2026-Q1: 2.36M shares2026-Q2: 2.36M shares
$1.19(+4.64%)
2026-06-30
ZNTL
ZENTALIS PHARMACEUTICALS INC
2.26%953.8K$3.9M
+0.00%(+0)
2025-Q2: 953.8K shares2025-Q3: 953.8K shares2025-Q4: 953.8K shares2026-Q1: 953.8K shares2026-Q2: 953.8K shares
$3.36(+23.70%)
2026-06-30
ORIC
ORIC PHARMACEUTICALS INC
2.09%372.9K$3.6M
-92.20%(-4.41M)
2025-Q2: 5.38M shares2025-Q3: 5.38M shares2025-Q4: 5.38M shares2026-Q1: 4.78M shares2026-Q2: 372.9K shares
$9.16(+47.98%)
2026-06-30

About Pfizer INC’s portfolio

Pfizer INC reports $170.37M in US-listed equity holdings across 17 positions in its most recent 13F filing. Its largest disclosed positions are ALLO (27.6%), CELC (17.4%) and ARVN (16.2%). The top 20 holdings account for 100.02% of reported assets. Its disclosed equity book has returned +34.29% cumulatively over 6 quarters. Figures reflect the Q2 2026 filing.

Portfolio concentration

Portfolio concentration
ALLO — 27.5% ($46.93M)CELC — 17.3% ($29.55M)ARVN — 16.2% ($27.66M)PYXS — 11.4% ($19.48M)WVE — 6.4% ($10.93M)BHVN — 4.7% ($8.00M)CRBU — 4.6% ($7.88M)SPRO — 3.1% ($5.34M)ZNTL — 2.3% ($3.85M)ORIC — 2.1% ($3.55M)Other — 4.2% ($7.18M)
96%in top 10
  • ALLO27.5%
  • CELC17.3%
  • ARVN16.2%
  • PYXS11.4%
  • WVE6.4%
  • BHVN4.7%
  • CRBU4.6%
  • SPRO3.1%
  • ZNTL2.3%
  • ORIC2.1%
  • Other4.2%

Portfolio changes

What the fund actually did

Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.

Trimmed
3
ORICORIC PHARMACEUTICALS INC-92.2%
ZURAZURA BIO LTD-81.0%
NXTCNEXTCURE INC-71.1%

Unlock alerts, watchlists & AI chat

Sign up free to track Pfizer INC, compare funds side by side, and get alerts the moment positions change.

Source filings

Holdings on this page are parsed from Pfizer INC’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 78003). View Pfizer INC’s 13F filings on SEC

More 13F analyses

View all